Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012739 (
disseminated intravascular coagulation
)
8,673
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
XMAP215
, a microtubule-associated protein isolated from Xenopus eggs, promotes microtubule assembly dynamics in an end-specific manner: addition of
XMAP215
to purified porcine tubulin increases both elongation and shortening rates at microtubule plus ends, with minimal effects at minus ends. Previous results indicated that
XMAP215
is phosphorylated during M phase, suggesting that its activity may be regulated by cell cycle phosphorylation. To test this hypothesis, we used video-enhanced
DIC
microscopy to examine the effects of
XMAP215
phosphorylated by CDK1 on the assembly of purified tubulin.
XMAP215
incubated with ATP at 30 degrees C for 10- 20 min in the absence of CDK1 exhibited a 4.1-fold increase in plus end elongation rate compared to purified tubulin. Elongation was promoted to a lesser degree (2.4-fold) by phosphorylated
XMAP215
. In contrast,
XMAP215
phosphorylation did not alter the approximately 3-fold increase in shortening rate.
XMAP215
binding to taxol microtubules was also not changed by phosphorylation. To further investigate mechanisms responsible for the faster microtubule shortening rate observed with
XMAP215
, we made microtubules with segments assembled prior to
XMAP215
addition (proximal segments) and segments assembled in the presence of
XMAP215
(distal segments). In 9 of 10 microtubules, the distal segment shortened faster (distal = 60.7 microm/min; proximal = 37.5 microm/min), suggesting that MTs assembled in the presence of
XMAP215
have an altered lattice that results in subsequent faster shortening.
...
PMID:Phosphorylation by CDK1 regulates XMAP215 function in vitro. 1042 72